TY - JOUR
T1 - Children's Bronchiectasis Education Advocacy and Research Network (Child-BEAR-Net)
T2 - An ERS Clinical Research Collaboration on improving outcomes of children and adolescents with bronchiectasis
AU - Chang, Anne B.
AU - Boyd, Jeanette
AU - Bush, Andrew
AU - Grimwood, Keith
AU - Hill, Adam T.
AU - Powell, Zena
AU - Yerkovich, Stephanie
AU - Zacharasiewicz, Angela
AU - Kantar, Ahmad
AU - Alexopoulou, Efthymia
AU - Bell, Leanne
AU - Chalmers, James D.
AU - Collaro, Andrew
AU - Constant, Carolina
AU - Douros, Kostas
AU - Fortescue, Rebecca
AU - Griese, Matthias
AU - Grigg, Jonathan
AU - Hector, Andreas
AU - Karadag, Bulent
AU - Mazulov, Oleksandr
AU - Midulla, Fabio
AU - Möller, Alexander
AU - Proesmans, Marijke
AU - Wilson, Christine
N1 - Funding Information:
Conflict of interest: A.B. Chang reports grants from National Health and Medical Research Council, Australia (NHMRC) during the conduct of the study; and that they are an independent data monitoring committee member for an unlicensed vaccine (GlaxoSmithKline), and advisory member of study design for unlicensed molecule for chronic cough (Merck), and an independent data monitoring committee member for a COVID-19 vaccine for children (Moderna), outside the submitted work. J. Boyd is an employee of the European Lung Foundation. A. Bush has nothing to disclose. K. Grimwood reports grants from National Health and Medical Research Council, Australia (NHMRC), during the conduct of the study. A.T. Hill has nothing to disclose. Z. Powell has nothing to declare. S. Yerkovich has nothing to disclose. A. Zacharasiewicz has nothing to disclose. A. Kantar has nothing to disclose.
Publisher Copyright:
© The authors 2021
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Child-BEAR-Net will create vital infrastructure to progress education, advocacy and research collaboration in paediatric bronchiectasis (see www.improveBE.org). With the ELF and parent advisory group, our initial planned projects respond to identified needs and complement the ERS paediatric bronchiectasis CPG [5]. Our CRC will advance bronchiectasis by raising awareness and encouraging an evidence-based approach to diagnosis and management. In doing so, this will improve the lives of the many children at risk of, or affected by, bronchiectasis.
AB - Child-BEAR-Net will create vital infrastructure to progress education, advocacy and research collaboration in paediatric bronchiectasis (see www.improveBE.org). With the ELF and parent advisory group, our initial planned projects respond to identified needs and complement the ERS paediatric bronchiectasis CPG [5]. Our CRC will advance bronchiectasis by raising awareness and encouraging an evidence-based approach to diagnosis and management. In doing so, this will improve the lives of the many children at risk of, or affected by, bronchiectasis.
UR - http://www.scopus.com/inward/record.url?scp=85120581920&partnerID=8YFLogxK
U2 - 10.1183/13993003.01657-2021
DO - 10.1183/13993003.01657-2021
M3 - Review article
C2 - 34675034
AN - SCOPUS:85120581920
VL - 58
SP - 1
EP - 5
JO - European Respiratory Journal
JF - European Respiratory Journal
SN - 0903-1936
IS - 4
M1 - 2101657
ER -